Quotation
“——
C4 Therapeutics (Nasdaq: CCCC) reported Q3 2025 results and program updates on November 6, 2025. Key highlights include a completed equity offering that raised $125 million in gross proceeds $225 million if outstanding warrants are exercised), which the company says extends its runway to end of 2028.——“
投資の参考になりましたか?

